Steroid Dose and Duration, Immortal Time Bias, and Survival After High-grade Immune-Related Adverse Events

JAMA Oncol. 2023 May 1;9(5):723-724. doi: 10.1001/jamaoncol.2023.0100.

Authors

Pankti Reid¹, Jeffrey A Sparks², Anne R Bass³

Affiliations

¹ Division of Rheumatology, University of Chicago Medical Center, Chicago, Illinois.
² Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts.
³ Hospital for Special Surgery, Division of Rheumatology, Weill Cornell Medicine, New York, New York.

PMID: 36892846
DOI: 10.1001/jamaoncol.2023.0100

No abstract available

Publication types

Letter
Comment

MeSH terms

Bias
Humans
Steroids*
Time Factors

Substances

Steroids